Here's how Arizona bioscience construction boom impacts region
Bioscience momentum in Arizona is continuing to build — especially when it comes to bioscience building and construction.
Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bioscience momentum in Arizona is continuing to build — especially when it comes to bioscience building and construction.
/PRNewswire/ -- In the near future, the antimicrobial resistance surveillance industry is poised to undergo a transformative evolution, driven by advances in...
On September 13, 2023, Jack Phillips, the CEO of Accelerate Diagnostics Inc (NASDAQ:AXDX), sold 733 shares of the company.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report) – Equities researchers at William Blair boosted their Q3 2023 earnings per share estimates for Accelerate Diagnostics in a research report issued to clients and investors on Monday, August 14th. William Blair analyst A. Brackmann now forecasts that the medical research company will earn ($0.94) per share for […]
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totalling 437,400 shares, a growth of 8.4% from the July 15th total of 403,500 shares. Based on an average daily trading volume, of 27,500 […]